Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 118432918 | 11843291 | 8 | F | 20121204 | 20160721 | 20151216 | 20160727 | EXP | PHHY2012CA104495 | NOVARTIS | 62.18 | YR | M | Y | 0.00000 | 20160727 | OT | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 118432918 | 11843291 | 1 | PS | SANDOSTATIN | OCTREOTIDE ACETATE | 1 | Subcutaneous | TID, ON AND OFF | Y | 19667 | TID | ||||||||
| 118432918 | 11843291 | 2 | SS | SANDOSTATIN | OCTREOTIDE ACETATE | 1 | Y | 19667 | |||||||||||
| 118432918 | 11843291 | 3 | SS | SANDOSTATIN LAR DEPOT | OCTREOTIDE ACETATE | 1 | Intramuscular | 30 MG, QMO (ONCE A MONTH) | U | 0 | 30 | MG | /month | ||||||
| 118432918 | 11843291 | 4 | SS | SANDOSTATIN LAR DEPOT | OCTREOTIDE ACETATE | 1 | U | 0 | |||||||||||
| 118432918 | 11843291 | 5 | SS | AFINITOR | EVEROLIMUS | 1 | Oral | 10 MG, QD | Y | 0 | 10 | MG | TABLET | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 118432918 | 11843291 | 1 | Hepatic cancer metastatic |
| 118432918 | 11843291 | 2 | Gastrointestinal surgery |
| 118432918 | 11843291 | 3 | Hepatic cancer metastatic |
| 118432918 | 11843291 | 4 | Gastrointestinal surgery |
| 118432918 | 11843291 | 5 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 118432918 | 11843291 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 118432918 | 11843291 | Abdominal pain | |
| 118432918 | 11843291 | Asthenia | |
| 118432918 | 11843291 | Blood creatinine increased | |
| 118432918 | 11843291 | Blood pressure increased | |
| 118432918 | 11843291 | Blood pressure systolic increased | |
| 118432918 | 11843291 | Body temperature decreased | |
| 118432918 | 11843291 | Chromaturia | |
| 118432918 | 11843291 | Erythema | |
| 118432918 | 11843291 | Escherichia infection | |
| 118432918 | 11843291 | Feeling cold | |
| 118432918 | 11843291 | Heart rate decreased | |
| 118432918 | 11843291 | Influenza | |
| 118432918 | 11843291 | Product use issue | |
| 118432918 | 11843291 | Renal disorder | |
| 118432918 | 11843291 | Stress | |
| 118432918 | 11843291 | Weight decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 118432918 | 11843291 | 1 | 2006 | 2010 | 0 | |
| 118432918 | 11843291 | 3 | 20120910 | 0 | ||
| 118432918 | 11843291 | 5 | 2016 | 201603 | 0 |